MAPT and Alzheimer disease: An EC-specific astrocyte signature was identified, characterized by the upregulation of genes such as APP and APOE, alongside the downregulation of SLC1A2 (glutamate transporter) and MAPT (tau protein), suggesting a role for these genes in the vulnerability of EC astrocytes to AD (Serrano-Pozo et al., 2024).